Jhpiego’s Daniel Were represented the Kenyan oral PrEP scale-up project at a WHO-sponsored satellite session during the 9th International AIDS Society Conference on HIV Science in Paris. Co-presenters included U.S. Global AIDS Coordinator Ambassador Deborah Birx; Rachel Baggaley of the HIV department at WHO; Yogan Pillay of the National Department of Health, South Africa; South African epidemiologist Quarraisha Abdool Karim; Sheena McCormack, a clinical epidemiologist at UCL; and Jean-Michelle Molina, an infectious disease specialist at the University of Paris Diderot. Moderating the session was Dr. Wafaa El-Sadr, founder and director of ICAP.
Oral Pre-Exposure Prophylaxis (PrEP) for an AIDS-Free Generation
A single pill taken daily to prevent HIV
Oral PrEP Works!
A daily dose is more than 90% effective in preventing HIV.
The World Health Organization (WHO) recommends oral PrEP to anyone at substantial risk for becoming infected with HIV and includes PrEP on the Essential Medicines List. A dozen clinical trials have proven that taking oral PrEP as prescribed prevents HIV.
*Fonner VA, Dalglish SL, Kennedy CE, et al. 2016. Effectiveness and safety of oral HIV pre-exposure prophylaxis for all populations. AIDS. 30(12):1973–1983. doi: 10.1097/QAD.0000000000001145.
Who Needs Oral PrEP?
Anyone who is HIV-negative and at substantial risk of becoming infected with HIV
Examples of those who may particularly benefit from PrEP include:
- adolescent girls and young women in areas where HIV is common
- HIV-negative men or women in a relationship with an HIV-positive person
- men who have sex with men
- sex workers
- those with behavioral risks that make it easier to get HIV
Bridge-to-Scale in Kenya
One of the largest national oral PrEP programs
Scale-up of routine oral PrEP services to over 22,000 people at risk for HIV
A global learning laboratory for governments and stakeholders considering oral PrEP policy and programs
Support from the Bill & Melinda Gates Foundation
The Jhpiego Difference
Trusted relationships with governments and international stakeholders
Close collaboration with WHO to make oral PrEP web-based training available to clinicians and pharmacists
Proven experience scaling up large and challenging interventions
Prior experience translating science to public health practice that is affordable, effective and sustainable.